𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tremor in Parkinson disease: acute response to oral levodopa

✍ Scribed by G. Tedeschi; E. Sasso; R. W. Marshall; V. Bonavita


Publisher
Springer Milan
Year
1990
Tongue
English
Weight
351 KB
Volume
11
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Levodopa response in early Parkinson's d
✍ Robert A. Hauser; Peggy Auinger; David Oakes πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Clozapine-responsive tremor in Parkinson
✍ Dr. J. H. Friedman; M. C. Lannon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 451 KB

## Abstract Clozapine is an atypical neuroleptic medication that is free of parkinsonian side effects and that has been reported to ameliorate the tremor of Parkinson's disease. We report (with videotape illustration) the dramatic improvement of severe yet classic rest tremors in one elderly nonpsy

Longitudinal study of the motor response
✍ Benjamin G. Clissold; Craig D. McColl; Katrina R. Reardon; Mark Shiff; Peter A. πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Abstract In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined __off__ states at 3 yearly intervals over a mean period of 11.4 years from the point of commencement of levodopa treatment. Twenty

Cerebral atrophy and long-term response
✍ E. Schneider; P.-A. Fischer; P. Jacobi; H. Becker; M. Beyer πŸ“‚ Article πŸ“… 1979 πŸ› Springer 🌐 English βš– 437 KB

In 92 parkinsonian patients (42 men, 50 women) aged from 37-79 years (mean 62.8) the impact of cerebral atrophy as assessed by computed tomography on the course of the clinical symptomatology under levodopa during a period of 1 to 5 years was investigated. It could be shown that patients suffering f